BioSpace News Archive

Policy

Myriad Applauds the U.S. Preventive Services Task Force Recommendation on BRCA-Related Cancer Prevention

More Women May Benefit from Hereditary Cancer Risk Assessment and Genetic Testing

August 22, 2019

·

7 min read

Deals

Freeze and Thaw Systems Market Continues to Benefit from Biopharma Companies, Gains Remain Concentrated in ‘Disposable’ Systems

A report on the freeze & thaw systems market which considers the global industry analysis 2014 – 2018 and forecast 2019-2029 projects that, the freeze & thaw systems market is expected to reach ~ US$ 270 Mn by the end of 2019 in terms of value, and is forecasted to reach ~ US$ 550 Bn by the end of 2029.

August 22, 2019

·

3 min read

Job Trends

Denver Health to Reduce Unnecessary Antibiotic Use in Young Children with Ear Infections

Denver Health Foundation has been awarded a grant from The Gerber Foundation to fund a research project, the NO TEARS study, looking at ear infections, the most common childhood infection.

August 22, 2019

·

2 min read

ViiV’s Two-Drug HIV Treatment Reduces Dosing Regimen, Study Shows

ViiV Healthcare’s two-month injection proved to be as effective as monthly injections for HIV treatment that are currently on the market, the GlaxoSmithKline subsidiary said this morning as it continues to position itself for a leading share of the market alongside Gilead Sciences.

August 22, 2019

·

3 min read

·

Alex Keown

Biotech Beach

Research Roundup: Genes Related to Sex Differences in Cancer Aggression and More

Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.

August 22, 2019

·

4 min read

·

Mark Terry

Why Do Some Neurological-Focused Drugs Work in Mice and Not Humans?

Preclinical data that show successful outcomes in mice often generate excitement in the news, but when it comes to treating humans with the same condition, typically neurological disorders like Alzheimer’s disease or glioblastoma, oftentimes the drugs do not work.

August 22, 2019

·

3 min read

·

Alex Keown

Vivoryon Therapeutics AG to Publish its Half Year 2019 Results on August 29, 2019

Vivoryon Therapeutics AG, will publish its Half Year Results for 2019 on Thursday, August 29, 2019.

August 22, 2019

·

4 min read

denovoMATRIX Introduces Ready-To-Use, Chemically Defined Coated Cell Cultureware for Serum-Free hMSC Expansion

Due to their high accessibility and extensive beneficial properties, human Mesenchymal Stem Cells offer exciting promises in a plethora of applications in regenerative medicine, particularly in cell-based therapies.

August 22, 2019

·

1 min read

Job Trends

rfxcel Will Exhibit at CPhI Middle East & Africa, the Largest Pharmaceutical Event in the Region

rfxcel, the global leader in supply chain track and trace solutions, will exhibit at this year’s CPhI Middle East & Africa conference in Abu Dhabi, United Arab Emirates.

August 22, 2019

·

2 min read

Lone Star Bio

An Unlikely New Target for Glioblastoma Drugs Found

Researchers led by Texas A&M University’s College of Veterinary Medicine & Biomedical Sciences have identified a new pathway they believe may help suppress the development of glioblastoma tumors.

August 22, 2019

·

3 min read

·

Mark Terry